These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28627817)

  • 1. Turbidimetric Determination of Fecal Calprotectin Using Two Table Top Chemistry Analyzers: Mindray BS-200E and Cobas® c111.
    Mandic-Havelka A; Nilsen T; Sunde K; Norell M; Hansson LO; Larsson A
    Clin Lab; 2017 May; 63(5):907-913. PubMed ID: 28627817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers.
    Nilsen T; Sunde K; Hansson LO; Havelka AM; Larsson A
    J Clin Lab Anal; 2017 Jul; 31(4):. PubMed ID: 27629827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference Intervals for Fecal Calprotectin in Adults Using Two Different Extraction Methods in the Uppsala-SCAPIS Cohort.
    Fall T; Mandic-Havelka A; Helmersson-Karlqvist J; Sundstrom J; Larsson A
    Clin Lab; 2017 Sep; 63(9):1493-1496. PubMed ID: 28879709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting.
    Noebauer B; Ramic L; Konstantin A; Zachbauer C; Einwallner E
    Biochem Med (Zagreb); 2017 Oct; 27(3):030710. PubMed ID: 29180918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
    Kittanakom S; Shajib MS; Garvie K; Turner J; Brooks D; Odeh S; Issenman R; Chetty VT; Macri J; Khan WI
    Can J Gastroenterol Hepatol; 2017; 2017():1450970. PubMed ID: 28491862
    [No Abstract]   [Full Text] [Related]  

  • 6. Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease.
    Oka A; Kawashima K; Kishimoto K; Kotani S; Fukunaga M; Fukuba N; Mishima Y; Oshima N; Ishimura N; Awoniyi M; Ishihara S
    Sci Rep; 2024 Jan; 14(1):1653. PubMed ID: 38238442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease.
    De Sloovere MMW; De Smet D; Baert FJ; Debrabandere J; Vanpoucke HJM
    Clin Chem Lab Med; 2017 Aug; 55(9):1435-1446. PubMed ID: 28076305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring calprotectin in plasma and blood with a fully automated turbidimetric assay.
    Åsberg A; Løfblad L; Felic A; Hov GG
    Scand J Clin Lab Invest; 2019; 79(1-2):50-57. PubMed ID: 30761918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability.
    Padoan A; D'Incà R; Scapellato ML; De Bastiani R; Caccaro R; Mescoli C; Moz S; Bozzato D; Zambon CF; Lorenzon G; Rugge M; Plebani M; Basso D
    Clin Chem Lab Med; 2018 Oct; 56(11):1926-1935. PubMed ID: 29729144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference Intervals for Fecal Calprotectin in Pregnant Women Using a Particle Enhanced Turbidimetric Assay.
    Fall T; Hedman A; Pershagen G; Andolf E; Almqvist C; Helmersson-Karlqvist J; Larsson A
    Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis.
    Hejl J; Theede K; Møllgren B; Madsen KV; Heidari A; Á Steig A; Fenger M
    Pract Lab Med; 2018 Mar; 10():10-14. PubMed ID: 29234707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Next-Generation Assays for Fecal Calprotectin vs the PhiCal Assay.
    Lin L; Wyness SP; Jensen R; Bird J; Norgyal T; Jensen G; Johnson LM
    Am J Clin Pathol; 2022 Feb; 157(2):252-256. PubMed ID: 34390332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the newly FDA-approved Buhlmann fCal Turbo assay for measurement of fecal calprotectin in a pediatric population.
    Garnett E; Pagaduan J; Rajapakshe D; Tam E; Kellermayer R; Devaraj S
    Pract Lab Med; 2020 Nov; 22():e00178. PubMed ID: 33134465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
    Malícková K; Janatková I; Bortlík M; Komárek V; Lukás M
    Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):147-53. PubMed ID: 19069028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the fCAL turbo immunoturbidimetric assay for measurement of calprotectin in porcine and bovine fecal samples.
    Pato R; Peña R; Pelegrí-Pineda A; Crusellas-Villorbina N; Pisoni L; Devant M; Marti S; Solà-Oriol D; Bassols A; Saco Y
    Res Vet Sci; 2023 Nov; 164():105042. PubMed ID: 37806097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a fluorescent immunochromatography test for fecal calprotectin.
    Li R; Zhao X; Dong J; Zhu D; Wang T; Yang S; Zhao Z; Xiao N
    J Clin Lab Anal; 2020 Feb; 34(2):e23059. PubMed ID: 31587371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
    Heida A; Knol M; Kobold AM; Bootsman J; Dijkstra G; van Rheenen PF
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1742-1749.e2. PubMed ID: 28606846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance Evaluation of Open Channel Buhlmann Fecal Calprotectin Turbo Assay on Abbott Alinity C Analyzer.
    Sataranatarajan K; Adhikari S; Nguyen N; Narasimhan M; Balani J; Muthukumar A
    Diagnostics (Basel); 2024 Aug; 14(16):. PubMed ID: 39202232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical Performance and Clinicopathologic Correlation of Four Fecal Calprotectin Methods.
    Pelkmans LPJ; de Groot MJM; Curvers J
    Am J Clin Pathol; 2019 Aug; 152(3):392-398. PubMed ID: 31152542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.